Cubist Systematic Strategies LLC Has $846,000 Position in The Pennant Group, Inc. (NASDAQ:PNTG)

Cubist Systematic Strategies LLC boosted its stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 210.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,887 shares of the company's stock after acquiring an additional 21,624 shares during the period. Cubist Systematic Strategies LLC owned 0.09% of The Pennant Group worth $846,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in PNTG. Van Berkom & Associates Inc. increased its stake in The Pennant Group by 2,635.6% during the 4th quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock worth $58,297,000 after acquiring an additional 2,117,859 shares during the period. FMR LLC increased its stake in shares of The Pennant Group by 54.5% in the 4th quarter. FMR LLC now owns 3,906,327 shares of the company's stock valued at $103,596,000 after purchasing an additional 1,377,815 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of The Pennant Group by 11.0% in the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock valued at $59,977,000 after purchasing an additional 223,919 shares during the last quarter. Ranger Investment Management L.P. increased its stake in shares of The Pennant Group by 147.3% in the 4th quarter. Ranger Investment Management L.P. now owns 195,210 shares of the company's stock valued at $5,177,000 after purchasing an additional 116,285 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of The Pennant Group in the 4th quarter valued at $2,570,000. Institutional investors own 85.88% of the company's stock.

Analyst Ratings Changes

PNTG has been the topic of several recent analyst reports. Truist Financial lifted their price target on The Pennant Group from $28.00 to $32.00 and gave the company a "hold" rating in a research note on Monday, May 12th. Stephens restated an "overweight" rating and set a $38.00 price objective on shares of The Pennant Group in a research report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, The Pennant Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.60.

The Pennant Group Price Performance

PNTG stock traded down $0.13 during midday trading on Tuesday, reaching $29.62. 18,914 shares of the stock were exchanged, compared to its average volume of 224,202. The stock has a market capitalization of $1.02 billion, a PE ratio of 43.55, a P/E/G ratio of 2.24 and a beta of 1.56. The Pennant Group, Inc. has a 52 week low of $21.18 and a 52 week high of $37.13. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The company has a fifty day moving average price of $25.84 and a 200 day moving average price of $27.17.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.